Allergan Inc (NYSE:AGN) Has Just Had Its TP Heightened by Research Analysts at Leerink Swann to $393.00
Stock Analysis:Allergan Inc (NYSE:AGN) Stock Target Upgraded In an interesting research report revealed to clients by Leerink Swann on Wednesday, 2 December, Allergan Inc (NYSE:AGN)…
